chr1-207468893-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001006658.3(CR2):c.728A>T(p.Asp243Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,613,478 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. D243D) has been classified as Likely benign.
Frequency
Consequence
NM_001006658.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CR2 | NM_001006658.3 | c.728A>T | p.Asp243Val | missense_variant | 4/20 | ENST00000367057.8 | |
CR2 | NM_001877.5 | c.728A>T | p.Asp243Val | missense_variant | 4/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CR2 | ENST00000367057.8 | c.728A>T | p.Asp243Val | missense_variant | 4/20 | 1 | NM_001006658.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000717 AC: 18AN: 251190Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135746
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461338Hom.: 0 Cov.: 32 AF XY: 0.0000193 AC XY: 14AN XY: 727006
GnomAD4 genome AF: 0.000158 AC: 24AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74318
ClinVar
Submissions by phenotype
Immunodeficiency, common variable, 7 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 23, 2022 | This sequence change replaces aspartic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 243 of the CR2 protein (p.Asp243Val). This variant is present in population databases (rs368883636, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with CR2-related conditions. ClinVar contains an entry for this variant (Variation ID: 571680). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2022 | The c.728A>T (p.D243V) alteration is located in exon 4 (coding exon 4) of the CR2 gene. This alteration results from a A to T substitution at nucleotide position 728, causing the aspartic acid (D) at amino acid position 243 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at